subscribeSubscribe
US FDA declines to approve Merck`s chronic cough drug

US FDA declines to approve Merck`s chronic cough drug

BUSINESSWIRE
21 Dec 2023
Share Share
FDA panel flags insufficient data for Merck`s chronic cough drug

FDA panel flags insufficient data for Merck`s chronic cough drug
REUTERS
18 Nov 2023
Share Share
FDA skeptical of Merck’s gefapixant, even after cough recount

FDA skeptical of Merck’s gefapixant, even after cough recount
Gabrielle Masson FIERCE BIOTECH
16 Nov 2023
Share Share
US FDA staff flags concerns about Merck`s chronic cough drug

US FDA staff flags concerns about Merck`s chronic cough drug
REUTERS
16 Nov 2023
Share Share
Merck`s Lyfnua (gefapixant) Receives Approval in Europe

Merck`s Lyfnua (gefapixant) Receives Approval in Europe
EMA
10 Oct 2023
Share Share
Merck Receives Positive European Union CHMP Opinion for Gefapixant

Merck Receives Positive European Union CHMP Opinion for Gefapixant
BUSINESSWIRE
21 Jul 2023
Share Share
GSK inks $2B Bellus buyout to challenge Merck for cough market

GSK inks $2B Bellus buyout to challenge Merck for cough market
Nick Paul Taylor FIERCE BIOTECH
19 Apr 2023
Share Share
Merck responds to FDA letter for chronic cough med gefapixant

Merck responds to FDA letter for chronic cough med gefapixant
Annalee Armstrong FIERCEBIOTECH
06 Aug 2022
Share Share
Merck drug for chronic cough rejected by FDA

Merck drug for chronic cough rejected by FDA
PRESS RELEASE
24 Jan 2022
Share Share
U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review

U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review
BUSINESSWIRE
25 Feb 2021
Share Share